A shadow economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Experimental Drug Gaining Traction Online
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Followers are urged to contact these profiles privately for source information, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Additionally, a robust trade exists on Telegram, where groups with thousands of members share comparison photos, injection guides and claims of next-day British shipping. Sellers promote the substance there before directing customers to other platforms for transactions.
Understanding The Experimental Drug
This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Medical Experts Voice Concerns
However, physicians and chemists have warned that the distribution of what remains an unapproved medication in the UK is worrisome and could lead to individuals administering products of unknown origin.
Some professionals stated the demand for retatrutide could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.
Legal Status and Enforcement
Marketing retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unapproved drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach pharmaceutical, advertising, and consumer laws, risking fines, prosecution or imprisonment.
Platform Response and Content Elimination
According to the social media company, the platform has taken down violative material and prohibited associated hashtags and query recommendations. The organization said it was committed to keeping the service safe and allocating resources in enhancing enforcement strategies.
Online Trading Operations
Investigations also discovered communities with up to 9,000 members selling the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up groups with thousands of users, populated with images of slimming results, glowing reviews and step-by-step guides for preparing or injecting at residence.
After minutes of joining one group, a vendor shared WhatsApp details, where most purchases take place. The vendor sent an instruction manual and promised delivery within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None inquired about body mass, medical conditions or previous experience.
Item Details and Pricing
Within these communities, posts display black plastic parcels with postal service labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with purified liquid, or pre-filled injectors typically sold at £160 for 20 milligrams. When asked how long a pen should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.
Platform Moderation and Security Measures
A spokesperson for Telegram said it regularly monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are injecting materials they cannot confirm. Although the research behind retatrutide is valid, these online products may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor linked the increase in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.
Her team has already seen individuals harmed by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company investigational substance not yet authorized … may expose patients to potentially significant health risks”.
